- Home
- HYPR vs FORA Comparison
HYPR vs FORA Comparison
Compare HYPR & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HYPR | FORA |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.9M | 66.2M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | HYPR | FORA |
|---|---|---|
| Price | $1.16 | $2.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.28 | N/A |
| AVG Volume (30 Days) | ★ 293.4K | 14.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.68 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $12,890,000.00 | ★ $20,153,263.00 |
| Revenue This Year | $5.96 | $51.82 |
| Revenue Next Year | $34.43 | $7.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 16.84 | N/A |
| 52 Week Low | $0.53 | $1.64 |
| 52 Week High | $2.22 | $2.71 |
Technical Indicators
Market Signals| Indicator | HYPR | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 56.48 | 40.38 |
| Support Level | $1.04 | $2.05 |
| Resistance Level | $1.19 | $2.12 |
| Average True Range (ATR) | 0.07 | 0.02 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 72.09 | 3.00 |
Price Performance
Historical ComparisonAbout HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.